Skip to main content

Want a detailed portfolio tracker?

Mirum Pharmaceuticals (MIRM) P/E (2019 - 2026)

Mirum Pharmaceuticals (MIRM) P/E from Sep 30, 2019 to Jul 21, 2026. The TTM Mirum Pharmaceuticals (MIRM) P/E is -250.31. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mirum Pharmaceuticals (MIRM)

YearP/EChange
2026-250.31+48.18%
2025-168.92+653.26%
2024-22.42+220.71%
2023-6.99-61.77%
2022-18.29+219.76%
2021-5.72+27.14%
2020-4.50-73.16%
2019-16.76N/A

Comparison Mirum Pharmaceuticals (MIRM) P/E with competitors

Mirum Pharmaceuticals (MIRM) P/E is -250.31.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-100.03%
FGENFibroGen Inc0.24-100.10%
CHRSCoherus Biosciences Inc0.85-100.34%
FBIOFortress Biotech Inc0.95-100.38%
ORMPOramed Pharmaceuticals Inc1.50-100.60%
AGENAgenus Inc3.01-101.20%
INVAInnoviva Inc3.15-101.26%
VXRTVaxart Inc3.55-101.42%
CRMDCorMedix Inc3.63-101.45%
CVACCureVac N.V.4.45-101.78%
GLPGGalapagos NV4.86-101.94%
SRPTSarepta Therapeutics Inc4.88-101.95%
ABEOAbeona Therapeutics Inc5.39-102.15%
ABUSArbutus Biopharma Corp5.60-102.24%
ZVRAZevra Therapeutics Inc5.89-102.35%
SPROSpero Therapeutics Inc6.23-102.49%
CGENCompugen Ltd6.31-102.52%
RIGLRigel Pharmaceuticals6.87-102.75%
SLXNSilexion Therapeutics Corp7.30-102.91%
OMEROmeros Corporation9.26-103.70%
AUPHAurinia Pharmaceuticals Inc9.58-103.83%
PLXProtalix BioTherapeutics Inc10.89-104.35%
ACADAcadia Pharmaceuticals Inc11.73-104.69%
TBPHTheravance Biopharma Inc12.26-104.90%
ADMAAdma Biologics Inc12.42-104.96%
HRMYHarmony Biosciences Holdings Inc13.82-105.52%
SABSSAB Biotherapeutics Inc14.14-105.65%
NAGENiagen Bioscience Inc14.82-105.92%
INCYIncyte Corp15.82-106.32%
REGNRegeneron Pharmaceuticals Inc15.86-106.33%
PBYIPuma Biotechnology Inc17.32-106.92%
CPRXCatalyst Pharmaceuticals Inc17.44-106.97%
EXELExelixis Inc17.54-107.01%
TGTXTG Therapeutics Inc18.97-107.58%
MDXGMimedx Group Inc20.55-108.21%
XOMAXOMA Royalty Corp22.87-109.14%
ARGXArgen X SE24.30-109.71%
CTMXCytomX Therapeutics Inc24.82-109.92%
XOMAOXOMA Royalty Corp25.34-110.13%
HALOHalozyme Therapeutics Inc25.62-110.24%
XOMAPXOMA Royalty Corp25.67-110.26%
VRTXVertex Pharmaceuticals Inc27.99-111.18%
RPRXRoyalty Pharma plc - Class A28.69-111.46%
SLNOSoleno Therapeutics Inc29.02-111.59%
ASNDAscendis Pharma A/S30.09-112.02%
LGNDLigand Pharmaceuticals Inc - Class B37.91-115.15%
APLSApellis Pharmaceuticals Inc39.02-115.59%
BMRNBiomarin Pharmaceutical Inc42.21-116.86%
KRYSKrystal Biotech Inc45.34-118.11%
ONCBeiGene Ltd69.54-127.78%
PHARPharming Group N.V.75.03-129.97%
TECHBio-Techne Corp101.96-140.73%
VCELVericel Corp109.92-143.91%
ALNYAlnylam Pharmaceuticals Inc117.96-147.13%
GMABGenmab140.29-156.05%
TLXTelix Pharmaceuticals Ltd162.15-164.78%
CORTCorcept Therapeutics Inc212.86-185.04%